MedPath

江苏复旦复华药业有限公司

Ownership
-
Established
2010-10-13
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

NMPA:3

Drug Approvals

Lacosamide Tablets

Product Name
拉考沙胺片
Approval Number
国药准字H20234094
Approval Date
Dec 18, 2023
NMPA

Lacosamide Tablets

Product Name
拉考沙胺片
Approval Number
国药准字H20234095
Approval Date
Dec 18, 2023
NMPA

Tiopronin for Injection

Product Name
注射用硫普罗宁
Approval Number
国药准字H20194074
Approval Date
Oct 8, 2019
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.